Merit Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.1M Sell
142,932
-4,830
-3% -$262K 0.04% 375
2026
Q1
$9.27M Buy
147,762
+11,745
+9% +$940K 0.07% 240
2025
Q4
$13M Sell
136,017
-5,178
-4% -$508K 0.1% 162
2025
Q3
$13.8M Buy
141,195
+6,267
+5% +$649K 0.13% 132
2025
Q2
$14.5M Buy
134,928
+14,508
+12% +$1.47M 0.16% 103
2025
Q1
$12.1M Buy
120,420
+12,938
+12% +$1.3M 0.18% 94
2024
Q4
$9.6M Buy
107,482
+11,502
+12% +$1.01M 0.17% 114
2024
Q3
$8.04M Sell
95,980
-9,639
-9% -$760K 0.18% 100
2024
Q2
$8.13M Buy
105,619
+4,204
+4% +$308K 0.18% 95
2024
Q1
$7.39M Buy
101,415
+9,141
+10% +$588K 0.18% 99
2023
Q4
$5.33M Buy
92,274
+7,162
+8% +$382K 0.16% 92
2023
Q3
$4.49M Sell
85,112
-10,224
-11% -$536K 0.15% 109
2023
Q2
$5.16M Buy
95,336
+2,630
+3% +$137K 0.17% 96
2023
Q1
$4.64M Buy
92,706
+2,096
+2% +$98.8K 0.17% 92
2022
Q4
$4.19M Buy
90,610
+18,745
+26% +$812K 0.15% 100
2022
Q3
$2.78M Buy
+71,865
New +$2.88M 0.12% 120
2020
Q1
Sell
-5,263
Closed -$238K 226
2019
Q4
$238K Buy
+5,263
New +$220K 0.02% 211

Other funds holding BSX

Merit Financial Group's BSX Position: Q2 2026 in Review

Merit Financial Group reduced its Boston Scientific (BSX) stake by 3.3% in Q2 2026, selling an estimated $262K and leaving 142,932 shares worth $6.1M. The position accounts for 0.04% of the portfolio, ranked #375.

Merit Financial Group first reported a position in BSX in Q4 2019 and has held it in 17 quarters since. The position peaked at $14.5M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Merit Financial Group held 142,932 shares of Boston Scientific worth $6.1M as of Q2 2026.
  • Merit Financial Group sold 4,830 Boston Scientific shares in Q2 2026, an estimated $262K.
  • Boston Scientific made up 0.04% of Merit Financial Group's portfolio in Q2 2026, its #375 holding.
  • Merit Financial Group first reported a position in Boston Scientific in Q4 2019 and has held it in 17 quarters since.
  • Merit Financial Group's Boston Scientific position peaked at $14.5M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.